Additional Information
| Name | SAMSCA® Tolvaptan 15mg tablets |
| Description | Tolvaptan is a selective vasopressin V2-receptor antagonist that specifically blocks the binding of arginine vasopressin (AVP) at the V2-receptor of the distal portions of the nephron. Tolvaptan affinity for the human V2-receptor is 1.8 times that of native AVP. |
| Active Ingredient | tolvaptan |
| Indication | Samsca is indicated in adults for the treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion (SIADH). |
| Strengths | Samsca 7.5 mg tablets Each tablet contains 7.5 mg tolvaptan. Samsca 15 mg tablets Each tablet contains 15 mg tolvaptan. Samsca 30 mg tablets Each tablet contains 30 mg tolvaptan. |
Related Products
Related products
Disclaimer
Pharma Solution is the marketing agent and Distributor for the listed products for the Gulf and MENA region. The products are either registered and approved by the respective local health authority or contracted by the MAH to supply to the end users on a named patient basis. Some products such as Orphan drugs, rare diseases medicines are imported based on special import permits and as per need of the Hospitals in compliance with full documentation.